NCT00518453View on ClinicalTrials.gov

Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008

PHASE2CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

Surface antigen inactivated influenza vaccine

1 dose of Fluvirin 2007/2008 Northern Hemisphere vaccine composition

Trial Locations (1)

Unknown

The Health Centre, Suffolk

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY